血栓调节蛋白和组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物在热射病中的诊断价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

中国医药教育 学会2022科学攻关科研课题(2022KTZ013) ;全军热射病防治能力建设专项


Clinical significance of thrombomodulin and tisue plasminogen activ ator- plasminogen activator inhibitor-1 complex in heat-stroke
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的探讨热射病时血栓调节蛋白(TM)和组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物(t-PAIC)的临床价值。方法回顾性分析解放军联勤保障部队第九O八医院重症医学科2016年6月至2022年9月收治的45例中暑患者,根据中暑严重程度分为热衰竭组(n=23)和热射病组(n=22)。收集患者入科2h内的常规凝血项目和血栓弹力图(TEG)指标以及血栓标志物TM、凝血酶-抗凝血酶复合物(TAT).纤溶酶-az纤溶酶抑制剂复合物( PIC)、t-PAIC,并进行统计学分析。结果与热衰竭组患者TM[7.3(5.4 ,9.3)TU/mL] .TAT[ 2.6( 1.5,7.2 )ng/mL]、PIC[0.7( 0.4, 1.0) μug/ mL]、t-PAIC[3.8(2.1,7.0)ng/mL]相比,热射病组患者TM[17.1(9.2 ,24.7)TU/ mL] TAT[ 23.4( 10.4, 44.3) ng/mL]、PIC[ 2.0(0.9 ,5.2)μug/mL]和t-PAIC. [ 17.0( 8.3,44.1)ng/mlL]均升高(P<0.05)。 单因素联合多因素Logistic 回归分析显示,TM及t-PAIC为发生热射病的独立危险因素(P<0.05)。TM联合t-PAIC诊断热射病的ROC曲线下面积为0.916(95% CI :0.839-0.993, P<0.001),当TM>8.2 TU/mL、t-PAIC>8.7 ng/mL时,敏感性为95.5% ,特异性为69.6%,阳性预测值为75.0%, 阴性预测值为94.1%。结论热射病患 者的TM、TAT、PIC和-PAIC可升高,TM联合t-PAIC对热射病诊断有临床价值。

    Abstract:

    Abstract : Objective To investigate the clinical significance of thrombomodulin (TM) and tssue plasminogen activator-plasminogen activator inhibitor-1 complex ( tPAIC) in heatstroke. Methods A retrospective analysis was conducted on 45 heatstroke patients admitted to the Intensive Care Unit of the 908th Hospital of PLA Logistic Support Force from June 2016 to September 2022. The patients were divided into 2 groups : heat exhaustion group( n=23) and heatstroke group( n=22) according to the severity of heat ilness. The results of conventional coagul ation tests, thromboelastogram ( TEG),and coagulation markers,including TM,thrombin antithrombin complex (TAT) , plasmin-a2 anti-pl asmin inhibitor complex ( PIC) and t-PAIC within 2 hours after admission, were statistically analyzed. Results Conpared with the heat exhaustion patients, the plasma levels of TM [17.1 (9.2, 24.7) vs 7.3(5.4, 9.3 )TU/mL],TAT [23.4 (10.4, 44.3) vs 2.6( 1.5, 7.2)ng/mL], PIC [2.0 (0.9, 5.2) vs 0.7(0.4, 1.0) μg/mL] and t-PAIC [17.0 (8.3, 44.1 vs 3.8(2.1, 7.0) ng/mL] in the heat stroke patients were significantly increased ( P<0.05 ). Combining univariate and multivariate Logistic regression analysis, TM and t-PAIC were shown as the independent risk factors for heatstroke. The area under the ROC curve of TM combined with t-PAIC was 0.916 ( 95%CI:0.839 to 0.993, P<0.001). When TM>8.2 TU/mL, t-PAIC>8.7 ng/ mL, the sensitivity,specifieity, positive predictive value and negative predictive value were 95.5%,69.6%, 75.0%, and 94.1% , respectively. Conclusion The levels of TM, TAT, PIC and t-PAIC of the patients with heatstrokk may si gnificantly increase. The results of TM combined with t-PAIC should be of clinical value in the diagnosis of heatstroke.

    参考文献
    相似文献
    引证文献
引用本文

何龙平,宋景春,彭恩兰,钟林翠,林青伟,宋晓敏,邓星平,窦建林.血栓调节蛋白和组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物在热射病中的诊断价值[J].临床检验杂志,2023,41(01):17-21

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-11-30
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-22
  • 出版日期:
您是第位访问者  苏ICP备12051282号-1
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司